Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Search results for: network

Study Groups: Where Information and Networking Mix

  |  

ACR study groups provide an excellent forum for networking at the ACR/ARHP Annual Scientific Meeting and are among the most highly sought-after sessions each year. Although study groups are not eligible for CME credits, they provide an opportunity for the exchange of new ideas and in-depth presentations of information. These groups give attendees the opportunity to discuss cases and share experiences with colleagues who share a common interest in one disease, a group of related disorders, or a specialized field of study.

Can Cultural Humility Conquer Systemic Inequity in Pediatric Rheumatology?

  |  

Doctors and patient advocates urged the rheumatology community to address the drastic inadequacies in care faced by marginalized people in a session held at ACR Convergence 2024.

The Management of Psoriatic Arthritis: A Review

  |  

WASHINGTON, D.C.—As of November 2024, there are 16 biologic disease-modifying anti-rheumatic drugs (bDMARDs) that are FDA approved for the treatment of psoriatic arthritis (PsA). Incredible news, right? But as my fellowship program director used to say, “There’s no free lunch.” This buffet of options is excellent for our patients, but poses challenges to the practicing…